Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0025362 (
mental retardation
)
15,878
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A new gene (
239FB
) with predominant and differential expression in fetal brain has recently been isolated from a chromosome 11p13-p14 boundary area near FSHB. The corresponding mRNA has an open reading frame of 294 amino acids, a 3' untranslated region of 1247 nucleotides, and a highly GC-rich 5' untranslated region. The coding and 3' UT sequence is specified by 6 exons within nearly 87 kb of isolated genomic locus. The 5' end region of the transcript maps adjacent to the only genomically defined CpG island in a chromosomal subregion that may be associated with part of the
mental retardation
of some WAGR (Wilms tumor, aniridia, genitourinary anomalies, and
mental retardation
) syndrome patients. In addition to nucleotide and amino acid similarity to an EST from a normalized infant brain cDNA library, the predicted protein has extensive similarity to two Caenorhabditis elegans polypeptides of, as yet, unknown function. The
239FB
locus is, therefore, likely part of a family of genes with two members expressed in human brain. The extensive conservation of the predicted protein suggests a fundamental function of the gene product and will enable evaluation of the role of the
239FB
gene in neurogenesis in model organisms.
...
PMID:cDNA sequence, genomic organization, and evolutionary conservation of a novel gene from the WAGR region. 866 3
A novel family of genes expressed in human brain has recently been identified. Gene
239FB
, transcribed extensively in fetal brain, was isolated from the chromosome 11p13 region associated with
mental retardation
component of the WAGR (Wilms tumor, aniridia, genitourinary anomalies,
mental retardation
) syndrome. This report presents a cDNA sequence and expression profile of a related gene, 239AB, isolated from adult brain library, that was mapped to chromosome 22. While similar in structure, the two genes differ in their expression pattern and may have different roles in central nervous system development and function. In contrast to the
239FB
, which is expressed predominantly in fetal brain, the 239AB gene is transcribed in adult tissues. Both human genes encode novel proteins of unknown function that are highly conserved from Caenorhabditis elegans to birds and mammals. Phylogenetic analysis suggested that the two lineages of the ancient gene family represented by
239FB
and 239AB have been in existence prior to the emergence of modern animals.
...
PMID:The 239AB gene on chromosome 22: a novel member of an ancient gene family. 926 72
Among the human diseases that result from chromosomal aberrations, a de novo deletion in chromosome 11p13 is clinically associated with a syndrome characterized by Wilms' tumor, aniridia, genitourinary anomalies, and
mental retardation
(WAGR). Not all genes in the deleted region have been characterized biochemically or functionally. We have recently identified the first Class III cyclic nucleotide phosphodiesterase, Rv0805, from Mycobacterium tuberculosis, which biochemically and structurally belongs to the superfamily of metallophosphoesterases. We performed a large scale bioinformatic analysis to identify orthologs of the Rv0805 protein and identified many eukaryotic genes that included the human
239FB
gene present in the region deleted in the WAGR syndrome. We report here the first detailed biochemical characterization of the rat
239FB
protein and show that it possesses metallophosphodiesterase activity. Extensive mutational analysis identified residues that are involved in metal interaction at the binuclear metal center. Generation of a rat
239FB
protein with a mutation corresponding to a single nucleotide polymorphism seen in human
239FB
led to complete inactivation of the protein. A close ortholog of
239FB
is found in adult tissues, and biochemical characterization of the 239AB protein demonstrated significant hydrolytic activity against 2',3'-cAMP, thus representing the first evidence for a Class III cyclic nucleotide phosphodiesterase in mammals. Highly conserved orthologs of the
239FB
protein are found in Caenorhabditis elegans and Drosophila and, coupled with available evidence suggesting that
239FB
is a tumor suppressor, indicate the important role this protein must play in diverse cellular events.
...
PMID:Characterization of an evolutionarily conserved metallophosphoesterase that is expressed in the fetal brain and associated with the WAGR syndrome. 1900 15